Phase 2Completed
Dry Eye Disease Study With Brimonidine
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Proof-of-Concept Study of Brimonidine Eye Drops for the Treatment of Dry Eye Disease (DED)
- Sponsor
- Ocugen (Industry)
- Enrollment
- 84 enrolled
- Conditions
- Dry Eye
- Interventions
- Brimonidine; Brimonidine Mono Therapy; sodium carboxymethylcellulose; Corticosteroid Eye Drop
- Ages
- adults, older adults
- Registry
- NCT03418727
Full record on ClinicalTrials.gov
From the registry
To evaluate the tolerability and preliminary efficacy of Brimonidine eye drops (with and without corticosteroid eye drops) for the treatment of Dry Eye Disease (DED).
Primary outcomes
- Tolerance of Test Substance Visual Analogue Scale (VAS) Score
History
Results first posted
Last registry update
Primary completion
Registered
Started